Younger men benefit most from surgery for localized prostate cancer

A new study by researchers from Uppsala University Hospital, Sweden, Harvard School of Public Health (HSPH) and colleagues—which draws from one of the few randomized trials conducted to directly address determining course of treatment for men with prostate cancer—finds a substantial long-term reduction in mortality for men with localized cancer who undergo a radical prostatectomy. While the benefit on mortality appears to be limited to men less than age 65, surgery did reduce the risk of metastases and need for additional treatment in older men. Read more here.